What is Ironwood Pharmaceuticals's short-term borrowings?

Ironwood Pharmaceuticals (IRWD) reported short-term borrowings of $199.86M in Q1 2026.

What is the long-term trend for Ironwood Pharmaceuticals's short-term borrowings?

Over 2 years (2021 to 2025), Ironwood Pharmaceuticals's short-term borrowings has grown at a 30.7% compound annual growth rate (CAGR), from $116.86M to $199.68M.

What does short-term borrowings mean?

Bank lines of credit, revolving credit facilities, and other short-term debt instruments with maturities under one year.

Ironwood Pharmaceuticals IRWD Short-Term Borrowings

Short-Term Borrowings at other companies

Ionis PharmaceuticalsIONS

$432.5M—

Other financials

Income statement

See full

Revenue$106.5M+159%

Operating income$72.6M+349%

Net income$40.8M+209%

EPS (diluted)$0.24+204%

Balance sheet

See full

Cash & equivalents$220.5M+103%

Total debt$212.4M+1,323%

Total equity-$217.1M+35.0%

Total assets$434.6M+32.8%

Cash flow

See full

Operating cash flow$5.1M-74.3%

CapEx-—

Free cash flow$74.6M+390%

Valuation

See full

Market cap$632.12M+457%

Enterprise value$624M+3,024%

P/E6.2×—

P/S1.8×+1.4×

Profitability

See full

Gross margin99.2%—

Operating margin55.4%+38.7pp

Net margin28.3%+22.3pp

FCF margin24.7%-11.1pp

Returns & leverage

See full

Return on equity29.7%-138pp

Debt / equity0×-0.5×

Current ratio1.4×-1.9×

Where this comes from

Reported directly by Ironwood Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebtCurrent.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's short-term borrowings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ironwood Pharmaceuticals's short-term borrowings?: Ironwood Pharmaceuticals (IRWD) reported short-term borrowings of $199.86M in Q1 2026.
What is the long-term trend for Ironwood Pharmaceuticals's short-term borrowings?: Over 2 years (2021 to 2025), Ironwood Pharmaceuticals's short-term borrowings has grown at a 30.7% compound annual growth rate (CAGR), from $116.86M to $199.68M.
What does short-term borrowings mean?: Bank lines of credit, revolving credit facilities, and other short-term debt instruments with maturities under one year.